Herbal Composition for Severe COVID-19 With Low Blood Oxygen
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of specific medicine for treating coronavirus infectious diseases, particularly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which often leads to severe illness with high mortality and requires supportive care due to the absence of effective therapeutic drugs.
Innovation Solution
A Chinese medicine composition comprising specific herbal extracts is administered to patients, including Ephedra sinica, Armeniacae Semen amarum, Glycyrrhizae radix et rhizoma, and others, formulated into a mixture and administered orally or via injection to inhibit virus replication and alleviate complications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If supportive care is applied to control and alleviate complications, then patient pain is reduced and survival is extended, but the treatment lacks specific therapeutic effect against the coronavirus itself
Solution Approach 1:
The patent segments the treatment approach by dividing the herbal composition into multiple functional components, each targeting specific pathological mechanisms of COVID-19. The composition includes herbs for antiviral effects, anti-inflammatory effects, immune modulation, and symptom relief, allowing multi-targeted therapy against the coronavirus while maintaining specific therapeutic action
Solution Approach 2:
The patent employs a composite herbal formulation combining multiple traditional Chinese medicines with complementary functions. This composite approach integrates antiviral, anti-inflammatory, immunomodulatory, and symptomatic relief properties into a single therapeutic agent, providing specific treatment against coronavirus while addressing multiple pathological aspects simultaneously
2Reliability
If traditional Chinese medicine is used to treat coronavirus infectious diseases, then therapeutic effects are achieved, but the composition and dosage must be precisely controlled to ensure safety and efficacy
Solution Approach 1:
The patent specifies precise quantitative parameters for each herbal ingredient in the composition, with defined weight ratios and dosage ranges. This parameter control ensures consistent therapeutic effects while maintaining safety standards. The formulation includes specific amounts of each herb (e.g., Ephedra sinica 2-4 parts, Armeniacae Semen amarum 7-9 parts) to optimize the balance between efficacy and safety
Solution Approach 2:
The patent assigns different functional qualities to different herbal components based on their specific therapeutic properties. Each herb is selected and dosed according to its particular strength and function within the overall treatment strategy, allowing precise control over the therapeutic profile of the composition while addressing specific pathological mechanisms
Data Source
AI summary
The present invention relates to a method for treating a coronavirus infectious disease and a complication thereof, including: administering a Chinese medicine composition to a subject in need thereof; wherein, the Chinese medicine composition is an extract of a first mixture including Ephedra sinica, Armeniacae Semen amarum, Glycyrrhizae radix et rhizoma, Gypsum fibrosum, Descurainiea semen, stephaniae Tetrandrae radix, Scutellariae radix, Poria, rhizoma alismatis, Polyporus umbellatus, Atractylodis rhizoma, Asteris radix et rhizoma, Tussilago farfara, Pinelliae rhizoma, and Rhei radix et rhizoma.